ACCESS Newswire

AlzeCure Pharma

11.10.2021 10:21:54 CEST | ACCESS Newswire | Press release

Share
AlzeCure Presents at Redeye Neurology (CNS) Seminar on October 13

STOCKHOLM, SE / ACCESSWIRE / October 11, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company is participating at Redeye Neurology (CNS) Seminar on October 13 at 10:55 CEST, where CSO Johan Sandin will present the company's latest developments. The presentation will be followed by a panel discussion together with representatives from AlziNova and BioArctic and moderated by Redeye's analysts.

The presentation will be held in English and live streamed via https://www.redeye.se/events/815803/neurology-seminar-cns-3 . The presentation will also be available afterwards on AlzeCure's website https://www.alzecurepharma.se/en/presentations-and-interviews/ .

For more information, please contact

Martin Jönsson, CEO
Tel: +46 707 86 94 43
martin.jonsson@alzecurepharma.com

About AlzeCure Pharma AB (publ)

AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.

NeuroRestore consists of two symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer's disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson's disease. The Alzstatin platform focuses on developing disease-modifying and preventive drug candidates for early treatment of Alzheimer's disease and comprises two drug candidates. Painless is the company's research platform in the field of pain and contains two projects: ACD440, which is a drug candidate in the clinical development phase for the treatment of neuropathic pain, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development to an early clinical phase, and is continually working on business development to find suitable outlicensing solutions with other pharmaceutical companies.

FNCA Sweden AB, +46(0)8 528 00 399 info@fnca.se, is the company's Certified Adviser. For more information, please visit www.alzecurepharma.se.

Image Attachments

Johan Sandin CSO AlzeCure Pharma

Attachments

AlzeCure presents at Redeye Neurology (CNS) Seminar on October 13

SOURCE: AlzeCure Pharma



View source version on accesswire.com:
https://www.accesswire.com/667525/AlzeCure-Presents-at-Redeye-Neurology-CNS-Seminar-on-October-13

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

EnSmart Power and Powerverse Partner to Unlock the Full Value of EV Charging and Home Energy8.4.2026 08:00:00 CEST | Press release

LONDON, UK / ACCESS Newswire / April 8, 2026 / Powerverse today announces a strategic partnership with EnSmart Power, a global leader in energy storage, power conversion, and smart energy solutions. The partnership combines Ensmart's hardware with Powerverse's intelligent software platform, creating a connected, app-driven home solution that unlocks energy optimisation and flexibility services. Combining EnSmart Power's expertise as one of the UK's largest providers of home energy storage systems and a global specialist in power supplies and power conversion, with Powerverse's AI-driven platform that enables home energy orchestration and maximises participation in energy flexibility, the partnership creates a powerful, end-to-end solution. Together, they empower homes to unlock smarter, cleaner, and more cost-effective energy. "By combining EnSmart's proven hardware expertise with Powerverse's AI-driven orchestration platform, we're unlocking the full potential of the connected home,"

Polaris Renewable Energy Announces Q1 2026 Investor Call Details8.4.2026 01:35:00 CEST | Press release

TORONTO, ON / ACCESS Newswire / April 7, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce it will be holding its Earnings Conference Call and Webcast to report its Q1 2026 Earnings Results on Thursday, May 7th, 2026, at 10:00 am EST. To listen to the call, please dial Toll Free 1888-506-0062 or International Toll-Free Number 973-528-0011 entry code 939001. or URL: https://www.webcaster5.com/Webcast/Page/2773/53516 A digital recording of the earnings call will be available for replay two hours after the call's completion. Replay Call Information: Toronto: 1 877-481-4010, Passcode: 53516 International (toll-free): 1 919-882-2331, Passcode: 53516 Encore Replay Expiration Date: May 21, 2026 About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the acquisition, development, and operation of renewable energy projects in Latin America and the Caribbean. We are a high-performing and f

Formerra Announces Global Price Increase7.4.2026 22:00:00 CEST | Press release

CLEVELAND, OH / ACCESS Newswire / April 7, 2026 / Formerra, a leading distributor of performance materials, today announced a global price increase of $0.02 / lb on all products. The increase addresses higher operating costs related to rising material costs, exacerbated by the conflict in the Middle East. The adjustment goes into effect on April 15, 2026, or as contracts otherwise allow. Formerra remains committed to maintaining ample inventory levels and the service excellence our valued customers deserve. Customers should contact their Formerra representative for additional information. About Formerra Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce c

Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG7.4.2026 15:00:00 CEST | Press release

CALGARY, AB / ACCESS Newswire / April 7, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today announced a strategic collaboration with carbon-connect AG ("carbon-connect"), a Switzerland-based greenhouse gas (GHG) accounting and sustainability advisory firm. The collaboration marks a continued expansion of Karbon-X's enterprise climate platform, strengthening its carbon measurement, decarbonization advisory, and ongoing monitoring capabilities for corporate and regulated clients. Karbon-X will lead commercial engagement and client integration, incorporating carbon-connect's technical expertise into its end-to-end climate solutions framework. The enhanced service offering includes: Full Scope 1,2, and 3 emissions accounting Emissions abatement planning and implementation Country-specific compliance, ESG, and sustainability reporting Product carbon quantificatio

U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler7.4.2026 13:00:00 CEST | Press release

USPA Gold Cup Finals to Air on ESPN and Global Polo Platforms WEST PALM BEACH, FL / ACCESS Newswire / April 7, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the USPA Gold Cup® at the USPA National Polo Center (NPC) in Wellington, Florida on April 5, 2026, Easter Sunday in front of a record crowd at the U.S. Polo Assn. Stadium Field.1. 2026 USPA Gold Cup Winners, Team Pilot (#1 Curtis Pilot - 0, #2 Mackenzie Weisz - 6, #3 Lorenzo Chavanne - 7, #4 Camilo ‘Jeta' Castagnola - 10) on stage with iconic trophy at the USPA National Polo Center - Wellington, Florida 2. Cousins, but rivals on the field - Pilot's Camilo ‘Jeta' Castagnola and La Dolfina Scone's Poroto Cambiaso battle for the ball at the 2026 USPA Gold Cup Final Photo Credit: Augustina Fonda As the second most prestigious tournament in the United States and a critical leg of the Gauntlet of Polo®, the USPA Gold Cup brings together the sport's top players and elite

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye